Invest & partner

Invest in or partner with a Bhutan biotech startup

We are opening conversations with seed investors and industry partners who see the value in Himalayan natural-product discovery.

Who we want to talk to

Investors

Seed and impact capital

Back an early, capital-light bet on AI-driven natural-product discovery, structured through Gelephu Mindfulness City.

Industry partners

Pharma and nutraceutical companies

Co-develop leads from Himalayan botanicals, or license validated formulations and data.

Research partners

Labs and universities

Co-design validation studies, share assay capacity, and supervise joint student projects in natural products and computational biology.

How BBCRI plans to earn revenue

Capital-light by design: services earn early, while partnerships and products build long-term value.

  1. Platform (Near-term)AI tools: digitised formulas, compound–target maps, docking and ADMET prediction. Customers: Universities, CROs and research teams.
  2. Research services (Near-term)Contract work in network pharmacology and in-silico screening, built on the same platform. Customers: Institutions, agencies and companies.
  3. Evidence-backed products (Mid-term)Standardised, scientifically validated formulations from Himalayan botanicals, sold under our own brand or licensed to partners. Customers: Wellness brands and consumers.
  4. Discovery partnerships (Long-term)Co-develop natural-product leads with industry partners through research fees, milestone payments and royalties. Customers: Pharma and nutraceutical companies.

What makes this hard to copy

Proprietary data

Digitised, structured Sowa Rigpa formulas linked to plants, compounds and targets: a dataset that does not exist anywhere else.

Compliant access

Built around Bhutan's access and benefit-sharing framework and the Nagoya Protocol, crediting knowledge holders. Lawful access is a barrier competitors cannot easily cross.

Capital-light, AI-first

Computation narrows thousands of candidates before any lab work, and partners run the assays. Less burn, faster answers.

Evidence over claims

Nothing is called a therapy until it is validated. That discipline is what partners, regulators and customers pay for.

Milestones

  1. Foundation (current phase)Working platform prototype; Register in Gelephu Mindfulness City; First pilot partners.
  2. SeedSeed funding; Curated plant, formula and compound database; Agreements with labs and Sowa Rigpa institutions.
  3. First revenueResearch services; First wet-lab validated leads; First evidence-backed product.
  4. ScaleCo-development deals with industry partners; Own R&D facility; Therapeutic and wellness product line.

Where we are, plainly

BBCRI is pre-revenue. We have a founding team and a working software prototype. We are registering in Gelephu Mindfulness City. The milestones above are plans, and plans can change.

Get in touch

Email ramesh@bbcri.online or call +975 77476075. You can also use the contact form on the home page. We reply to every message.

This page describes our plans for general information. Nothing here is an offer to sell, or a solicitation to buy, shares or any other investment. Any investment would be made only through separate legal documents.

Start a conversation.

Investors, partners and customers: tell us what you have in mind. We reply to every message.

Email ramesh@bbcri.online Invest or partner